Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

Do You Qualify for Defitelio Coverage by UnitedHealthcare in Illinois? Decision Tree & Next Steps

Answer Box: Quick Eligibility Assessment You likely qualify for Defitelio (defibrotide) coverage by UnitedHealthcare in Illinois if you have hepatic veno-occlusive disease (VOD/SOS) with organ dysfunction after stem cell transplant. The fastest path is submitting prior authorization through OptumRx with complete transplant documentation. If denied, Illinois law guarantees external
5 min read

How to Get Skyrizi (Risankizumab) Covered by UnitedHealthcare in Illinois: Complete Prior Authorization Guide with Forms and Appeals

Quick Answer: Getting Skyrizi Covered by UnitedHealthcare in Illinois UnitedHealthcare requires prior authorization for Skyrizi (risankizumab) in Illinois. The fastest path to approval: verify your diagnosis meets severity criteria, document failed topical therapies (for psoriasis) or TNF inhibitor failure (for psoriatic arthritis/IBD), complete TB screening, and submit via the
6 min read

How to Get Cresemba (Isavuconazole) Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization Guide

Answer Box: Getting Cresemba Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Cresemba (isavuconazole) in North Carolina through OptumRx. You'll need: confirmed invasive aspergillosis (B44.0) or mucormycosis (B46.x) diagnosis, documentation that voriconazole failed/can't be used, and infectious disease specialist consultation.
5 min read

How to Get HyperHEP Covered by UnitedHealthcare in Illinois: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting HyperHEP Covered by UnitedHealthcare in Illinois UnitedHealthcare requires prior authorization for HyperHEP (hepatitis B immune globulin) in Illinois. For fastest approval: (1) Document the exact exposure event and timing within 24 hours, (2) Submit PA through OptumRx with CDC-aligned medical necessity documentation, (3) If denied, file internal
7 min read

How to Get Brensocatib (BRINSUPRI) Covered by UnitedHealthcare in Illinois: Complete Appeals Guide 2025

Answer Box: Getting Brensocatib Covered by UnitedHealthcare in Illinois Brensocatib (BRINSUPRI) requires prior authorization from UnitedHealthcare through OptumRx. As Illinois' first-approved DPP1 inhibitor for bronchiectasis, expect initial denials due to step therapy requirements. Your fastest path: 1) Submit PA with documented macrolide failure and airway clearance trial, 2) Request
5 min read

Myths vs. Facts: Getting Fintepla (Fenfluramine) Covered by UnitedHealthcare in Ohio - Complete Appeals Guide

Answer Box: Getting Fintepla Covered by UnitedHealthcare in Ohio Fintepla (fenfluramine) requires prior authorization from UnitedHealthcare and strict REMS program compliance. Most denials stem from missing REMS documentation or incomplete step therapy records. First step today: Ensure your prescriber has enrolled in the Fintepla REMS program and completed your baseline
5 min read

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by UnitedHealthcare in North Carolina: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Lutathera Covered by UnitedHealthcare in North Carolina Lutathera requires prior authorization from UnitedHealthcare with strict step therapy requirements. You must show disease progression on octreotide LAR or lanreotide, plus SSTR-positive imaging (Ga-68 DOTATATE PET scan). If denied, appeals succeed in 85% of cases. Start today: Gather your
5 min read

Myths vs. Facts: Getting Kymriah (Tisagenlecleucel) Covered by UnitedHealthcare in Ohio

Answer Box: Getting Kymriah Covered by UnitedHealthcare in Ohio Yes, UnitedHealthcare covers Kymriah for FDA-approved indications, but prior authorization is required. Success depends on meeting clinical criteria, submitting complete documentation, and using certified treatment centers. First step: Have your oncologist initiate PA through the UnitedHealthcare Provider Portal with CD19+ status,
6 min read